Europe — EMA

Onkotrone (Mitoxantrone)

Mitoxantrone, the active ingredient in Onkotrone, is a antineoplastic presented as a 0 mg/0 ml for intravenous use. It treats certain cancers and is administered in hospital settings.

Mitoxantrone

Request sourcing

Pack/s

What is Mitoxantrone?

Mitoxantrone, the active ingredient in Onkotrone, is a antineoplastic presented as a 0 mg/0 ml for intravenous use. It treats certain cancers and is administered in hospital settings.

GNH USA supplies Onkotrone as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Mitoxantrone used for?

Onkotrone acts the ... ... ... ... ... ... ... ... .... .... ... ... ... .... - Acute Acute ... ... ... ... ... ...

What are the side effects of Mitoxantrone?

This ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →